61752-10-1

Basic information

• Product Name: benzyl 2-oxo-2H-pyran-5-carboxylate
• CAS NO: 61752-10-1
• Molecular Formula: C₁₃H₁₀O₄
• Molecular Weight: 230.2161
• Mol File: 61752-10-1.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 382.2°C at 760 mmHg
• Flash Point: 196.3°C
• Density: 1.301g/cm³
• Vapor Pressure: 4.8E-06mmHg at 25°C
• Refractive Index: 1.586
• CAS DataBase Reference: benzyl 2-oxo-2H-pyran-5-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 2-oxo-2H-pyran-5-carboxylate(61752-10-1)
• EPA Substance Registry System: benzyl 2-oxo-2H-pyran-5-carboxylate(61752-10-1)

Safety Data

• Hazardous Substances Data: 61752-10-1(Hazardous Substances Data)

Upstream product

• 500-05-0 2H-pyran-2-one-5-carboxylic acid 
• 100-51-6 benzyl alcohol 
• 100-44-7 benzyl chloride 

Downstream Products

• 1229575-93-2 benzyl 5-acetyl-4,6-dimethyl-1,4-dihydropyridine-3-carboxylate 
• 958778-49-9 C₂₃H₂₃NO₄ 

Relevant articles and documents

Design and synthesis of 1,4-dihydropyridine derivatives as BACE-1 inhibitors

BACE-1 has been shown to be an attractive therapeutic target in Alzheimer's disease (AD). Using a 1,4-dihydropyridine (DHP) scaffold, we synthesized new inhibitors of BACE-1 by modifying the known BACE inhibitor 2 containing a hydroxyethylamine (HEA) motif. Using structure-based drug design based on computer-aided molecular docking, the isophthalamide ring of 2 was replaced with a 1,4-dihydropyridine ring as a brain-targeting strategy. Several of the new dihydropyridine derivatives were synthesized and their BACE-1-inhibitory activities were evaluated using a cell-based, reporter gene assay system that measures the cleavage of alkaline phosphatase (AP)-APP fusion protein by BACE-1. Most of the 1,4-DHP analogs showed BACE-1-inhibitory activities with IC50 values in the range 8-30?μM, suggesting that the 1,4-DHP skeleton may be utilized to develop brain-targeting BACE-1 inhibitors.